Literature DB >> 1157404

Combined staged anterior and posterior correction and fusion of the spine in scoliosis following poliomyelitis.

J P O'Brien, A C Yau, S Gertzbein, A R Hodgson.   

Abstract

The problems with severe forms of scoliosis following poliomyelitis include the associated muscle imbalance, soft tissue contractures and pelvic obliquity. Such deformities militate against optimal correction and maintenance of that correction and their treatment is often marred by pseudarthroses. Seventeen patients with an average curve of 93 degrees have been treated and followed for up to 38 months. Preliminary traction was used in 8 patients, then a staged anterior and posterior correction and fusion was done, using Dwyer's instrumentation of the major curve in all and a Harrington rod to supplement the posterior fusion in eleven patients. With this technique the major curve was corrected by 80 per cent with an average 2 per cent loss over 18 months. No pseudarthroses were seen when the Harrington rod was used. Great care must be taken if halo-pelvic traction is to be used for patients with pelvic obliquity, for preliminary correction halo-femoral traction will often be adequate. In the more severe forms of paralytic scoliosis a combined staged anterior and posterior correction and fusion should be considered if the aim is maximal correction of the scoliosis and avoidance of pseudarthroses.

Entities:  

Mesh:

Year:  1975        PMID: 1157404     DOI: 10.1097/00003086-197507000-00013

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  The operative treatment of spinal deformities in MMC.

Authors:  C Hopf; M Schwarz; A Wackerhagen; D Voth
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

2.  Intrathecal Analgesic Drug Delivery is Effective for Analgesia in a Patient with Post-Poliomyelitis Syndrome: A Case Report.

Authors:  Cornelis W J van Tilburg
Journal:  Am J Case Rep       Date:  2016-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.